Molecular Insights and Emerging Strategies for Treatment of Metastatic Uveal Melanoma
Uveal melanoma (UM) is the most common intraocular cancer. In recent decades, major advances have been achieved in the diagnosis and prognosis of UM allowing for tailored treatments. However, nearly 50% of patients still develop metastatic disease with survival rates of less than 1 year. There is cu...
Main Authors: | Fabiana Mallone, Marta Sacchetti, Alessandro Lambiase, Antonietta Moramarco |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-09-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/12/10/2761 |
Similar Items
-
Treatment of Metastatic Uveal Melanoma: Systematic Review
by: Cristina Rodriguez-Vidal, et al.
Published: (2020-09-01) -
Metastatic Uveal Melanoma: Treatment Strategies and Survival—Results from the Dutch Melanoma Treatment Registry
by: Anouk Jochems, et al.
Published: (2019-07-01) -
Transcriptome Profiling Reveals New Insights into the Immune Microenvironment and Upregulation of Novel Biomarkers in Metastatic Uveal Melanoma
by: Yamini Krishna, et al.
Published: (2020-09-01) -
CURRENT CONCEPTS IN THERAPY OF UVEAL MELANOMA
by: Detanac Dženana A, et al.
Published: (2015-07-01) -
Genetic Landscape and Emerging Therapies in Uveal Melanoma
by: Rino S. Seedor, et al.
Published: (2021-11-01)